4.6 Editorial Material

Editorial: Multi-Target-Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation

期刊

FRONTIERS IN CHEMISTRY
卷 7, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fchem.2019.00071

关键词

multi-target paradigms; multi-target molecules; multidisciplinary cooperation; drug discovery; chemotheca; compliance; rational drug design

资金

  1. EU COST1 ACTION [CA15135]
  2. Estonian Ministry for Education and Research [IUT34-14]

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models

Matteo Staderini, Silvia Vanni, Arianna Colini Baldeschi, Gabriele Giachin, Marco Zattoni, Luigi Celauro, Chiara Ferracin, Edoardo Bistaffa, Fabio Moda, Daniel Perez, Ana Martinez, M. Antonia Martin, Olmo Martin-Camara, Angel Cores, Giulia Bianchini, Robert Kammerer, J. Carlos Menendez, Giuseppe Legname, Maria Laura Bolognesi

Summary: This study designed novel carbazole derivatives as pharmacological chaperones for prion diseases. These derivatives showed anti-prion activity and could detect prion protein aggregates through fluorescent staining. The compounds exhibited activity against RML-infected cell lines and have potential applications in the treatment of prion diseases.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

MedChemBlog: An Innovative Distance Learning Experience for Teaching Medicinal Chemistry

Giulia Panzarella, Gianmarco Gualtieri, Isabella Romeo, Stefano Alcaro

Summary: A qualified teaching method is difficult to achieve without traditional classroom lessons. However, in this innovative distance learning experiment, students have been able to change traditional teaching methods by creating a multimedia tool called MedChemBlog, which has improved their understanding of chemical structures and drug molecular mechanisms.

JOURNAL OF CHEMICAL EDUCATION (2023)

Article Biochemistry & Molecular Biology

Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands

Maria Dichiara, Francesca Alessandra Ambrosio, Carla Barbaraci, Rafael Gonzalez-Cano, Giosue Costa, Carmela Parenti, Agostino Marrazzo, Lorella Pasquinucci, Enrique J. Cobos, Stefano Alcaro, Emanuele Amata

Summary: The development of diazabicyclo[4.3.0]nonane and 2,7-diazaspiro[3.5]nonane derivatives as sigma receptors (SRs) ligands is discussed. The compounds were evaluated for their binding to S1R and S2R, and modeling studies were conducted to analyze the binding mode. Three notable compounds, 4b, 5b, and 8f, were further tested for their analgesic effects and functional profiles. Compound 4b showed S1R agonistic effects, while compounds 5b and 8f exhibited S1R antagonism.

ACS CHEMICAL NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein-Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches

Roberta Bivacqua, Isabella Romeo, Marilia Barreca, Paola Barraja, Stefano Alcaro, Alessandra Montalbano

Summary: Protein-protein interactions are an attractive target for drug design. This study focuses on the HSV-1 envelope glycoprotein D (gD) and identifies potential inhibitors for gD through protein-protein docking, dynamic simulations, and virtual screening. Four triazolo[4,5-b]pyridines are found to have good theoretical affinity towards all conformations of HSV-1 gD. This study provides a promising basis for the design of new antiviral agents targeting gD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Valorizing Constituents of Cashew Nut Shell Liquid toward the Sustainable Development of New Drugs against Chagas Disease

Lais Flavia Nunes Lemes, George E. Magoulas, Andressa Souza de Oliveira, Emile Barrias, Luciana de Camargo Nascente, Renato Granado, Sara Teixeira de Macedo Silva, Nikos Assimomytis, Wanderley de Souza, Maria Laura Bolognesi, Luiz Antonio Soares Romeiro, Theodora Calogeropoulou

Summary: Synthetic ether phospholipid analogues derived from cashew nut shell liquid exhibited potent antiparasitic activity against Trypanosoma cruzi, the causative agent of Chagas disease. Two compounds (16 and 17) showed higher selectivity indices against different developmental stages of T. cruzi compared to the current drug benznidazole. This study suggests that these analogues derived from inexpensive agro-waste materials have the potential to be developed as new treatments for Chagas disease.

ACS INFECTIOUS DISEASES (2023)

Article Oncology

Potential use of TG68-A novel thyromimetic-for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis

Andrea Caddeo, Marina Serra, Francesca Sedda, Andrea Bacci, Clementina Manera, Simona Rapposelli, Amedeo Columbano, Andrea Perra, Marta Anna Kowalik

Summary: The study found that TG68 has a therapeutic effect on NAFLD-associated hepatocarcinogenesis. It can significantly reduce hepatic fat accumulation, improve lipid and glucose levels, and restore the differentiation status of hepatocytes. This novel therapeutic strategy shows promise in the treatment of NAFLD-associated hepatocarcinogenesis.

FRONTIERS IN ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

Uncovering Novel Capsaicin Inhibitory Activity towards Human Carbonic Anhydrase Isoforms IX and XII by Combining In Silico and In Vitro Studies

Gianmarco Gualtieri, Annalisa Maruca, Roberta Rocca, Fabrizio Carta, Emanuela Berrino, Alessandro Salatino, Carolina Brescia, Roberta Torcasio, Manuel Crispo, Francesco Trapasso, Stefano Alcaro, Claudiu T. Supuran, Giosue Costa

Summary: Capsaicin, a bioactive spicy molecule found in hot peppers, has been extensively studied for its beneficial effects. This study used in silico methods to evaluate its inhibitory activity against tumor-associated human CA IX and XII. In vitro assays confirmed its inhibitory activity, and a non-small cell lung cancer model showed that Capsaicin can inhibit cell migration.

ANTIOXIDANTS (2023)

Editorial Material Biochemistry & Molecular Biology

New Synthetic Methodology for Drug-like Molecules

Graeme Barker, Simona Rapposelli

MOLECULES (2023)

Article Chemistry, Medicinal

Identification of HuR-RNA Interfering Compounds by Dynamic Combinatorial Chemistry and Fluorescence Polarization

Serena Della Volpe, Roberta Listro, Francesca Alessandra Ambrosio, Martina Garbagnoli, Pasquale Linciano, Daniela Rossi, Giosue Costa, Stefano Alcaro, Francesca Vasile, Anna K. H. Hirsch, Simona Collina

Summary: RNA binding protein HuR plays a role in the regulation of oncogenes and tumor suppressor genes, and its dysregulation is associated with cancer. This study utilized protein-templated dynamic combinatorial chemistry to search for novel HuR ligands that can interfere with the HuR-RNA complex. Several compounds were identified and shown to effectively interfere with HuR-RNA binding, indicating their potential as anticancer agents targeting HuR-RNA interactions.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Review Pharmacology & Pharmacy

BRCT Domains: Structure, Functions, and Implications in Disease-New Therapeutic Targets for Innovative Drug Discovery against Infections

Jose Pena-Guerrero, Celia Fernandez-Rubio, Alfonso T. T. Garcia-Sosa, Paul A. A. Nguewa

Summary: The BRCT domain is a potential therapeutic target due to its moderately conserved folding and high sequence variations. It plays critical roles in DNA repair, recombination, and cell cycle control, and is implicated in various pathologic processes including breast, ovarian, and lung cancer. This review explores the possible roles of BRCT domains as therapeutic targets and describes their common structural features, relevant interactions and pathways, as well as their implications in pathologic processes. Additionally, it presents drugs commonly used to target these domains and offers new drug design possibilities based on their structures.

PHARMACEUTICS (2023)

Article Chemistry, Medicinal

Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients

Carmen Gratteri, Francesca Alessandra Ambrosio, Antonio Lupia, Federica Moraca, Bruno Catalanotti, Giosue Costa, Maria Bellocchi, Luca Carioti, Romina Salpini, Francesca Ceccherini-Silberstein, Simone La Frazia, Vincenzo Malagnino, Loredana Sarmati, Valentina Svicher, Sharon Bryant, Anna Artese, Stefano Alcaro

Summary: This study evaluated the impact of RdRp mutations on the efficacy of remdesivir in treating COVID-19. Clinical observations revealed that patients with specific mutations showed a reduced response to remdesivir, accompanied by an increase in viral load and a decrease in binding affinity to RdRp. Computational approaches helped to explain these clinical observations by analyzing the effects of mutants on the viral RNA synthesis machine and the binding patterns of remdesivir.

PHARMACEUTICALS (2023)

Article Biochemistry & Molecular Biology

PROTAC-Induced Glycogen Synthase Kinase 3ß Degradation as a Potential Therapeutic Strategy for Alzheimer's Disease

Melissa Guardigni, Letizia Pruccoli, Alan Santini, Angela De Simone, Matteo Bersani, Francesca Spyrakis, Flavia Frabetti, Elisa Uliassi, Vincenza Andrisano, Barbara Pagliarani, Paula Fernandez-Gomez, Valle Palomo, Maria Laura Bolognesi, Andrea Tarozzi, Andrea Milelli

Summary: A small set of novel GSK-3β degraders were designed and synthesized using PROTAC technology. Compound 1 emerged as the most effective PROTAC, being nontoxic to neuronal cells and able to degrade GSK-3β in a dose-dependent manner. PROTAC 1 significantly reduced neurotoxicity induced by Aβ25-35 peptide and CuSO4.

ACS CHEMICAL NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2

Rebecca Ferrisi, Beatrice Polini, Caterina Ricardi, Francesca Gado, Kawthar A. A. Mohamed, Giovanna Baron, Salvatore Faiella, Giulio Poli, Simona Rapposelli, Giuseppe Saccomanni, Giancarlo Aldini, Grazia Chiellini, Robert B. B. Laprairie, Clementina Manera, Gabriella Ortore

Summary: We have developed a new generation of ligands (JR compounds) that target the CB2R. These compounds combine the pharmacophoric portion of CB2R positive allosteric modulator (EC21a) with that of CB2R selective orthosteric agonist (LV62). Among the tested compounds, JR22a showed dualsteric behavior as a CB2R ligand. Computational studies confirmed the binding mode of JR22a at CB2R, and its potential to prevent neuroinflammation was investigated using a human microglial cell model.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition

Vladimir Curcic, Mateusz Olszewski, Natalia Maciejewska, Aleksandar Visnjevac, Tatjana Srdic-Rajic, Vladimir Dobricic, Alfonso T. Garcia-Sosa, Sanja B. Kokanov, Jovana B. Araskov, Romano Silvestri, Roland Schuele, Manfred Jung, Milan Nikolic, Nenad R. Filipovic

Summary: Heterocyclic pharmacophores such as thiazole and quinoline rings play an important role in medicinal chemistry. This study focuses on the synthesis and evaluation of a series of novel thiazolyl-hydrazones based on quinoline and hydroxyquinoline moieties. The most promising compound, 2-(2-(quinolyl-8-ol-2-ylmethylene)hydrazinyl)-4-(4-methoxyphenyl)-1,3-thiazole (3c), shows significant anticancer activity by blocking cell-cycle progression, inducing DNA double-strand breaks, and inhibiting autophagy.

ARCHIV DER PHARMAZIE (2023)

Article Chemistry, Multidisciplinary

N-Substituted 3-Aminooxindoles and N-Propargyl Derivatives: Potential Biological Activities against Alzheimer's Disease

Tereza Hofmanova, Carolina Marques, Alfonso T. Garcia-Sosa, Oscar Lopez, Luisa Leitzbach, Elisabete P. Carreiro, Aday Gonzalez-Bakker, Adrian Puerta, Holger Stark, Jose M. Padron, Jose G. Fernandez-Bolanos, Anthony J. Burke

Summary: This study focuses on the synthesis and biological activity evaluation of a series of novel N-substituted 3-aminooxindoles, revealing their selective inhibition activity against butyrylcholinesterase and their potential as drug candidates for Alzheimer's disease.

RESULTS IN CHEMISTRY (2023)

暂无数据